Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.